Delivery Order SPE2DB20D6035-SPE2DB24FD2NK

Award Date 7/21/24
Potential Completion Date 8/9/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a contract award to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distribution company, to provide RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,448.20 and is a Firm Fixed Price Delivery Order, with a completion date of July 9, 2024. The contract is not set aside and was awarded on June 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,816.32, is a delivery order for 4567143430 RYANODEX 250 MG VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of February 24, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $4,287.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a completion date of February 23, 2023. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,210.88, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and was awarded on February 27, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded to AmerisourceBergen Drug Corp Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has a firm-fixed price ceiling value of $22,344.60 and a completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide 4567771250 RYANODEX 250 MG VIALS. The contract has a ceiling value of $3,210.88 and a period of performance through April 8, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,210.88 and is a Firm Fixed Price Delivery Order for RYANODEX 250 MG VIALS. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a potential value of $2,979.28 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide the pharmaceutical product RYANODEX 250MG VIAL 1S, with a total ceiling value of $5,958.56 and a period of performance through March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,632.64, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as...
  • SPE2DB20D6035
    Indefinite Delivery Contract
  • SPE2DB20D6035-SPE2DB24FD2NK
    Delivery Order

This is a delivery order contract award to AmerisourceBergen Drug Corp for $5,958.56 to provide RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA). The contract has a period of performance through August 9, 2024 and is a firm fixed price contract. This award is associated with a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. There is no set-aside designation for this specific award.

Generated 10/20/24, 9:01 AM